For the Clinician

Expected Benefits to the Clinician

Easy to use
VasoNova VPS can contribute to faster and more confident insertion, providing a clear indication of arrival at the desired location and quick indication if the PICC is travelling into the undesired veins, such as jugular, innominate, or azygos veins.
Potentially reduce risk of vessel damage due to notification by system
VasoNova VPS technology notifies the user when the catheter tip is close to the vessel wall, allowing the user to make real-time adjustments of the catheter instead of hitting the wall repeatedly. Multiple hits on the vessel wall may increase risk of vessel damage.
High level of confidence that tip is properly placed when system indicates the tip has arrived at desired location
Because most cardiac abnormalities do not affect placement outcome, when the VasoNova VPS indicates proper placement, the placement may be deemed to have arrived at the lower third of the SVC.
Not subject to electromagnetic interference
Setup of the VasoNova VPS is fast and easy, without calibration to zero-out an electromagnetic field.
Power injectable, trimmable polyurethane catheter with depth markings and reverse taper
Catheter plugs gently into the insertion site and reverse taper resists kinking at hub.

Expected Benefits to the Healthcare Facility

Fewer catheter re-positionings may contribute to:
- Reduced risk of infection
  Hospital-acquired infections (HAI) cost an estimated $45,000 per incident.¹¹ With less need for repositioning, the VasoNova VPS for PICC placement may reduce the risk of catheter-related infection. Full body drapes in Full kits also provide maximum barrier to aid in infection control.
- Minimizing X-ray requirements
  The VasoNova VPS may require only a single confirming X-ray post placement. This reduces X-ray cost and eliminates infusion delays, thereby increasing efficiency and throughput which saves valuable nursing time.
- Reduced labor costs
  Optimizing first attempt success rates may reduce overall labor costs for the facility, including extra nursing time, transportation time, overtime associated with confirmation and overflow due to delay.
- Increase throughput
  Rapid placement may minimize disruption of patient care, increase timeliness of medication administration and contribute to overall increase in throughput.

Expected Benefits to the Patient

VPS is designed to enable placement of the catheter correctly the first time
Since the VPS uses the patient's physiological characteristics to determine the catheter's location, clinicians know when the catheter is placed at the lower third of the SVC. This may reduce the need for adjustments and subsequent X-ray exposure, potentially reducing the patient's exposure to X-rays and related adverse outcomes from X-rays.
Improved likelihood of continuity of care
Use of the VPS may minimize disruption of care for the patient and increases timeliness of medication administration.
No external device on chest to induce potential discomfort
Without the nuisance of an external device placed on the patient's chest, the VasoNova VPS allows the patient to remain comfortable and breathe normally during the procedure.
Optimal placement improves infusion efficiency
Precise placement with the VasoNova VPS at the lower third of SVC, specifically at the CAJ, allows the turbulent blood flow at CAJ to quickly mix and dilute infused fluids, such as drugs, by the patient's blood, ensuring rapid transportation to the rest of the body.
Effective in many* patients, including those with AF, pacemakers, myocardial pathology, obesity or challenges with body habitus
Unlike other catheter placement technologies, the VasoNova VPS is not limited by the size of the patient or the pathophysiology of the heart.
Latex-free components to maximize comfort and safety
Increase safety for patients who are allergic to latex.

* Contraindicated for patients who cannot use a PICC line. See IFU for contraindications.